In 2004, the United States Congress passed the Prohibition on Mandatory Medication Amendment, a federal law that prevents schools from forcing parents to place children on psychiatric drugs as a condition of attending school. The Citizens Commission on Human Rights International (CCHR), a mental health industry watchdog, was instrumental in securing this legislation. The amendment, now part of the Code of Federal Regulations, was a response to widespread reports of school personnel coercing parents through threats of expulsion, involvement of Child Protective Services, or criminal charges of medical neglect. Many families had witnessed their children suffer severe side effects, including suicidal ideation and death.
The law was the culmination of years of advocacy by CCHR and other groups, who also pressured the Food and Drug Administration (FDA) to add black-box warnings about the risks of antidepressants. In 1991, CCHR was the first patient advocacy group to demand a public hearing before the FDA's Psychopharmacological Drugs Advisory Committee to investigate antidepressant-induced suicide and violence. Despite testimony from dozens of patients and family members, the panel, many of whom had financial ties to pharmaceutical companies, voted against label changes. It took another 13 years before the FDA mandated the black-box warnings on SSRIs.
The need for such protections was highlighted in a 2003 congressional hearing, where a senior staffer noted that CCHR's efforts increased awareness on Capitol Hill about the forced medication of children in schools. Congressman Dan Burton praised CCHR's contributions, stating, "Through united action, effective education and advocacy, CCHR has helped to bring about critically needed healthcare reform." The organization also worked with AbleChild.org and the National Foundation of Women Legislators to pass similar prohibitions in 12 states, building momentum for the federal effort.
Recent actions reflect a growing recognition of psychiatric drug risks. In May 2026, the U.S. Department of Health and Human Services announced initiatives to curb psychiatric overprescribing and assist those wishing to withdraw safely from antidepressants. On July 24, 2026, Florida Surgeon General Dr. Joseph A. Ladapo issued guidance recommending against the use of psychotropic drugs in children for mental health conditions, emphasizing the importance of a full physical examination and laboratory tests before any treatment. The United Kingdom had already called for deprescribing in 2024.
Jan Eastgate, President of CCHR International, noted, "The risk data was always available for anyone willing to listen to patients or press for the facts, and thanks to those who did, there is a cultural shift in the recognition of psychotropic drug risks and the need to be able to safely withdraw from them. They should never be forced onto any child or individual."
Since its founding in 1969 by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has fought for parental and children's rights and informed consent. The organization's Mental Health Declaration of Human Rights underscores the right to a physical examination before initiating treatment. A California pilot project in 1982, which CCHR helped establish, revealed that many psychiatric patients had undiagnosed physical diseases, leading to recommendations for comprehensive medical evaluations.
For over four decades, CCHR has been a leading voice in exposing abuses in the psychiatric industry and advocating for reforms. Its efforts have contributed to more than 190 worldwide protections. The 2004 federal law remains a cornerstone of these achievements, safeguarding children and families from coercive practices.
